Video
Dr. Siddiqui discusses recent and projected developments in bladder cancer
Author(s):
"Some of the discussion going on right now is how to improve the morbidity of bladder cancer treatment by pursuing such things…as bladder sparing approaches when feasible…and so, I think that’s very exciting,” says Mohummad M. Siddiqui, MD.
Video Player is loading.
In this video, Mohummad M. Siddiqui, MD, discusses recent developments in the bladder cancer space and shares highlights from the bladder cancer course presented at the 2021 Society of Urologic Oncology Annual Meeting. Siddiqui is an associate professor of surgery and director of urologic oncology and robotic surgery at the University of Maryland, Baltimore.
Related Videos
5 key trial insights from AUA 2025
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Alexander Glaser, MD, on real-world outcomes with Aquablation
Vitaly Margulis, MD, on preliminary safety, efficacy of padeliporfin VTP for UTUC
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Margaret Knoedler, MD, on Ho:YAG vs thulium fiber laser for ureteroscopy
John Gore, MD, on radical cystectomy vs bladder-sparing therapy for NMIBC
Related Content
